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Background: Immunization quality improvement programs are often limited by the cost and inconvenience
associated with delivering face-to-face consultations to primary care providers. To investigate a more efficient mode
of intervention delivery, we conducted a process evaluation that compared in-person consultations to those delivered
via interactive webinar.
Methods: The Centers for Disease Control and Prevention’s Assessment, Feedback, Incentives, and eXchange (AFIX)
Program is an immunization quality improvement program implemented in all 50 states. In 2011, we randomly
assigned 61 high-volume primary care clinics in North Carolina to receive an in-person or webinar AFIX consultation
focused on adolescent immunization. We used surveys of participating vaccine providers and expense tracking logs to
evaluate delivery modes on participation, satisfaction, and cost. Clinics served 71,874 patients, ages 11 to 18.
Results: Clinics that received in-person and webinar consultations reported similar levels of participation on key
programmatic activities with one exception: more webinar clinics reported improving documentation of previously
administered, ‘historical’ vaccine doses. Both in-person and webinar clinics showed sustained improvement in confidence
to use reminder/recall systems (both p < 0.05). Participants rated delivery modes equally highly on satisfaction measures
such as convenience (mean = 4.6 of 5.0). Delivery cost per clinic was $152 for in-person consultations versus $100 for
webinar consultations.
Conclusions: In-person and webinar delivery modes were both well received, but webinar AFIX consultations cost
substantially less. Interactive webinar delivery shows promise for considerably extending the reach of immunization
quality improvement programs.
Trial registration: Clinicaltrials.gov, NCT01544764
Keywords: Adolescent health services, Immunization programs, Health care quality, access, and evaluation, Quality
improvement, Process assessmentBackground
Adolescent immunization has emerged as a focus of
healthcare quality improvement for several reasons.
Adolescents in the U.S. are under-immunized. Despite
national guidelines for routine administration, coverage
for vaccines in the adolescent platform ranges from 85%
for tetanus, diphtheria, and pertussis (Tdap) to 74% for* Correspondence: ntb@unc.edu
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reproduction in any medium, provided the ormeningococcal conjugate to just 33% for completion of
the three-dose human papillomavirus (HPV) vaccine series
(females only) [1]. These coverage levels are dramatically
lower than for childhood vaccines, which typically achieve
coverage over 90% [2]. To improve levels of adolescent
vaccination, clinic-level interventions may be particularly
effective, since underuse appears to stem, in part, from
organizational and provider factors. For example, a leading
reason that adolescents are not up-to-date is that pro-
viders do not recommend adolescent vaccines in a timely
manner [1,3-5].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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formation systems, or vaccine registries, has provided
a means to address underuse [6]. These secure, electronic
databases offer access to population-based coverage data
needed for clinic-level benchmarking and evaluation.
Registries also support patient reminder/recall systems
and other strategies for improving vaccine delivery. Thus,
a persistent problem and the increasing availability of
tools to address that problem combine to make ado-
lescent immunization a compelling target for quality
improvement.
One model used to guide immunization quality im-
provement for adolescents is the Centers for Disease
Control and Prevention’s (CDC) Assessment, Feedback,
Incentives, and eXchange (AFIX) Program [7]. Developed
to improve immunization in early childhood, AFIX
employs an ‘assessment and feedback’ approach that
involves evaluating clinics’ vaccine coverage levels and
then delivering brief quality improvement consultations to
vaccine providers so as to address clinic-specific challenges
to immunization. Based on evidence that AFIX raises early
childhood immunization coverage by four to seven percent-
age points above secular trends [8-10], CDC recommends
that state and regional health departments provide AFIX
consultations to at least one-quarter of federally-funded
vaccine providers each year. To maximize reach, larger
clinics are prioritized, and many health departments suc-
ceed in not only meeting, but greatly exceeding CDC’s
25% goal. More recently, health departments have begun
using a modified version of AFIX in an attempt to address
the underuse of adolescent vaccines. Research to support
this work is limited, and the impact of AFIX on adolescent
immunization coverage has not, until present, been rigor-
ously evaluated.
To address this need, we conducted a randomized con-
trolled trial of adolescent AFIX consultations delivered to
high-volume primary care clinics in North Carolina. The
purpose of this trial was to evaluate the effectiveness of
AFIX with regard to raising adolescent immunization
coverage and to explore strategies for delivering consulta-
tions via interactive webinar versus in-person office visit.
In a three-arm trial with 91 clinics, we found that both
webinar and in-person AFIX consultations modestly
improved immunization coverage among adolescents,
ages 11 to 12, compared to no-consultation control
(Gilkey, Dayton, Moss, et al., in preparation). At five-
month follow-up, clinics in the in-person and webinar
conditions outperformed the control condition by three
to five percentage points for Tdap and meningococcal
vaccine coverage. Clinics in the intervention conditions
achieved small, but statistically significant, improvements
over the control clinics for HPV vaccination. Overall, our
findings suggest that AFIX holds promise for improving
adolescent immunization, but that the program needsfurther development with regard to HPV vaccination before
it should be adopted nationally.
Our finding that webinar delivery of AFIX raised adoles-
cent immunization coverage at least as much as in-person
delivery warrants further exploration. Webinar delivery
could substantially increase the reach of AFIX by eliminat-
ing the cost and inconvenience associated with traveling
to clinics to deliver in-person consultations. However, in
addition to cost, reach is also determined by participants’
willingness to engage in quality improvement efforts. For
this reason, webinar delivery must be acceptable to vac-
cine providers in addition to being low cost. To investigate
how delivery mode may impact the reach of adolescent
AFIX, we conducted a process evaluation with 61 clinics
in this study’s intervention arms to compare in-person
and webinar consultations on provider participation and
satisfaction as well as program cost.
Methods
Participants
We randomly selected 91 of 481 eligible clinics to partici-
pate in the study using the North Carolina Immunization
Registry (NCIR), the state’s immunization information
system. Used by over 90% of vaccine providers in the state,
NCIR is a secure, web-based database that contains
immunization information for 67% of North Carolina’s
adolescents [11]. Eligible clinics were pediatric or family
practice clinics with more than 200 patients, ages 11 to
18, with active records in the registry. Each clinic was
randomized to one of three conditions: in-person AFIX
consultation (30 clinics); webinar AFIX consultation
(31 clinics); or no consultation control (30 clinics). This
report focuses solely on the 61 clinics assigned to the in-
person and webinar intervention conditions; we did not
collect process data from the control clinics. The North
Carolina Division of Public Health Institutional Review
Board approved the study protocol.
Intervention
From April to August 2011, one immunization specialist
(AD) from the North Carolina Division of Public Health
delivered one adolescent AFIX consultation to each clinic
via interactive webinar or in-person office visit. Prior to
each meeting, the specialist prepared for the consultation
by using the state’s immunization registry to generate
reports related to the clinic’s baseline performance.
These reports included: the assessment report, which
listed the percentage of the clinic’s adolescent patients,
ages 11 to 18, who were up-to-date for targeted adolescent
and early childhood vaccines; the missing immunization
report, which identified patients who were due for one
or more vaccines; and the duplicate client report, which
identified patients who had duplicate records in the
registry.









Use all encounters to vaccinate 3.4 (1.0) 24
Use prompts like posters 3.0 (1.4) 13
Standing-orders for vaccination 3.4 (1.6) 11
Use adolescent catch-up schedule 3.9 (1.2) 7
Train staff on contraindications 3.9 (1.1) 6
Developing a reminder/recall system
Use reminder/recalls 2.2 (1.1) 40
Update patient contact information 3.5 (1.2) 12
Schedule ‘shots only’ visits 3.1 (1.4) 6
Schedule next visits in office 4.3 (0.8) 3
Establishing staff guidelines
Create immunization teams 3.2 (1.5) 15
Vaccinate when history is in doubt 3.2 (1.4) 14
Encourage well visits for ages 11-12 3.6 (1.4) 13
Provide resources to hesitant parents 3.9 (1.2) 10
Conduct immunization assessments 4.0 (1.3) 7
Administer multiple vaccines if due 4.6 (0.7) 2
Implement data best practices
Measure clinic’s immunization rates 2.4 (1.3) 30
Update parents’ vaccination records 3.8 (1.2) 14
Flag charts for due/over-due vaccines 3.5 (1.3) 10
Make shot record visible in chart 4.4 (0.9) 4
Require record of historical doses 4.2 (1.1) 3
Note. Use of these strategies at baseline was equally common in clinics in the
in-person and webinar conditions, except for use of adolescent catch-up
schedule (3.2, SD = 1.2 versus 2.5, SD = 1.3) and flag charts for due/over-due
vaccines (2.2, SD = 1.4 versus 2.9, SD = 1.2) (both p < .05).
aCurrent activity assessed using a five-point response scale ranging from ‘no
activity’ (1) to ‘optimal’ (5).
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sultation to the nurse who served as the clinic’s designated
immunization coordinator, although on several occasions
other staff members also attended. Consultations centered
on several components:
Assessment and feedback
The specialist began by sharing findings of the assessment
report that detailed the clinic’s immunization coverage
levels. She helped providers contextualize the assessment
findings by showing how the clinic compared to others in
the county and state.
Education and training
The specialist also provided hands-on training in im-
munization best practices on three topics. First, using the
duplicate client report, the specialist demonstrated how
providers could clean up registry records by deleting
duplicate or inactive records from the clinic’s roster and
by updating active records to reflect previously adminis-
tered, or historical, vaccine doses. Second, using the missing
immunization report, the specialist discussed the import-
ance of using reminder/recall systems to contact patients
due for vaccines, and she demonstrated how to use the
registry’s reminder/recall function. Third, the specialist
discussed strategies for reducing missed opportunities for
vaccination, which occur when patients receive some, but
not all, of the vaccines for which they are due.
Goal setting
Lastly, the specialist worked with providers to identify
goals for addressing clinic-specific challenges so as to
improve the clinic’s adolescent immunization coverage
levels. In-person and webinar consultations did not
differ in content. Webinar consultations used Adobe
Connect (Adobe Systems Incorporated, San Jose, CA), an
interactive conferencing platform that supported real-time
communication between the specialist and the provider.
This software included a screen sharing function that
allowed the specialist to remotely control the providers’
computer screen to demonstrate how to manipulate the
registry as she would during the course of an in-person
office visit. Given the need to orient providers to the
software, webinar consultations lasted about 90 minutes
on average in contrast to the 60 minutes needed to
complete an in-person consultation.
Procedure
Participants completed four written surveys for each clinic
over the course of the study.
Baseline survey
Participants completed this 19-item internet survey
prior to the AFIX consultation. Closed- and open-endedquestions assessed clinic policies and practices related to
adolescent immunization.Best practice assessment survey
Participants completed this written survey during the
AFIX consultation. Closed-ended questions assessed
each clinic’s current level of activity with regard to 20
immunization best practices in four domains: decreasing
missed opportunities; developing reminder/recall systems;
establishing staff guidelines for immunizations; and imple-
menting data handling procedures (Table 1). Along with
the immunization specialist, participants used this survey
to select one practice in each domain as a focus for their
quality improvement efforts.
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Participants completed this 12-item internet survey directly
after receiving the AFIX consultation. Closed- and open-
ended questions assessed participants’ experience of the
consultation.
Follow-up survey
Participants completed this 21-item internet survey five
months after receiving the AFIX consultation. Closed- and
open-ended questions assessed participants’ quality im-
provement activities since the consultation.
Measures
Participation
We assessed how and how much providers chose to
engage in quality improvement activities using several
sets of measures. First, we assessed baseline organizational
practices and goal endorsement using the best practice
assessment. Second, we assessed participants’ confidence
using reminder/recall systems with one item administered
in three surveys: baseline, evaluation, and five-month
follow-up. Third, we measured participants’ perceived
quality improvement effort via the follow-up survey, which
assessed effort related to key programmatic activities,
including use of reminder/recall systems.
Satisfaction
Satisfaction measures came from the evaluation survey.
This questionnaire assessed participants’ perceptions
of the AFIX consultation in terms of helpfulness, ease
of understanding, convenience, and length of consultation.
Participants also rated the importance of individual
program components, including: reports on immunization
coverage, missing immunizations, and duplicate clients;
coverage comparisons at the regional, state, and national
levels; and reminder/recall training. Finally, participants
indicated whether they would have preferred receiving the
intervention via in-person or webinar delivery.
Cost
Cost data came from expense tracking logs maintained
by the immunization specialist (AD). These logs detailed
expenses related to delivering the intervention, including:
staff time needed for consultation preparation, delivery
and travel; mileage reimbursement and lodging for over-
night trips; and mailing and webinar-hosting fees. This
analysis did not include costs incurred by participating
providers, patients, or parents.
Clinic characteristics
The North Carolina Immunization Registry provided data
on clinic characteristics, including the proportions of
adolescent patients who were black, white, or another
race and the proportions of vaccines doses administeredat the clinic that were either publicly or privately funded.
Publicly-funded doses were those for which a patient was
eligible for the Vaccines for Children (VFC) program [12].
VFC is a federally-financed program that provides free
vaccines for children and adolescents who are uninsured,
Medicaid-insured, or of American Indian or Alaska Native
descent; the program also provides vaccines for under-
insured youth through federally qualified health centers
and rural health clinics. We also assessed clinic specialty
(pediatric or family practice) and location. We defined
clinics located within a metropolitan statistical area as
‘urban or suburban’ and others as ‘rural’ [13].Statistical analysis
To check randomization, we assessed whether study arms
differed on clinic characteristics using chi-square tests and
analyses of variance. We used t-tests to compare clinics in
the in-person and webinar conditions on mean scores
related to participation (i.e., reminder/recall confidence,
quality improvement effort) and satisfaction. We calculated
intervention cost per clinic by dividing the total interven-
tion cost for each condition by the number of clinics in that
condition. We analyzed data using Stata Version 12.0
(Statacorp, College Station, TX). Statistical tests were two-
tailed with a critical alpha of 0.05.Results
Clinic characteristics
Of 61 clinics that received AFIX consultations, about half
(56%) specialized in pediatrics, and the rest specialized in
family medicine. Clinics served 71,874 adolescent patients
with active records in the immunization registry. These
records indicated that, on average, clinics’ patients were
predominantly white (50%) and black (23%); race was
unspecified for one-quarter (25%) of patients in the
sample. In each study arm, over one-third (42% on average)
of vaccine doses that clinics administered were eligible for
public funding through the Vaccines for Children program.
Most clinics (77%) were located in urban/suburban versus
rural counties. Clinics in the in-person and webinar condi-
tions did not differ on any of the clinic characteristics we
assessed.Participation
All 61 clinics assigned to the intervention conditions
completed full AFIX consultations and responded to
the pre-consultation, post-consultation, and five-month
follow-up surveys. Overall, 79% of respondents reported
sharing the findings of the clinic’s immunization cover-
age report with others, including one or more of their
clinics’ healthcare providers (n = 34) or office managers
(n = 14).
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Clinics in the in-person and webinar conditions rated
their baseline use of immunization best practices similarly.
Of 20 strategies for improving immunization rates, partici-
pants most often chose to focus their quality improvement
efforts on using reminder/recall systems (66%). They also
commonly chose measuring the clinic’s immunization
rates periodically (49%); using all encounters as opportun-
ities to provide vaccines (39%); and creating immunization
teams (25%). These popular strategies were among those
that participants rated most poorly in terms of their current
activity levels (Table 1).Reminder/recalls
On a five-point response scale, participants’ mean con-
fidence in running reminder/recalls increased from 2.7
(SD = 1.5) at pre-consultation to 4.4 (SD = 0.8) at post-
consultation (p < 0.001). Compared to pre-consultation
scores, mean confidence remained higher at five-month
follow-up (mean = 3.8, SD = 1.1, p < 0.001). Participants in
the webinar versus in-person conditions reported the
same levels of confidence at each of the three time points
(Figure 1).
In terms of self-reported use of reminder/recall systems,
51% of respondents reported making ‘more effort’ to use
any system between baseline and five-month follow-up,
and study arms did not differ on this measure (Figure 2).
At follow up, 43% of respondents in the in-person condi-
tion and 29% in the webinar condition reported having
run at least one recall using the immunization registry.
Among these respondents, the average number of recalls
completed at follow-up was 1.3 (SD = 1.0) for the in-person
condition and 2.6 (SD = 1.8) for the webinar condition.
Across intervention conditions, reasons named for not
using the registry’s reminder/recall system included lack
of staff or time (n = 18), the competing challenge of imple-


















Figure 1 Confidence in being able to run patient reminder/
recalls among staff at clinics in the in-person (k = 30) and
webinar (k = 31) conditions. Note: Bars show standard errors.use of a system other than the registry to perform recalls
(n = 4).
Other programmatic activities
At five-month follow-up, 84% of participants reported
having made more effort since baseline in entering histor-
ical vaccine doses into the registry. Over half of respondents
reported making more effort with two other activities:
targeting patients one office visit short of being fully
immunized (61%) or removing inactive patients from
the registry (56%). Of these three activities, we observed
statistically significant differences by intervention group
for only the entry of historical doses, with more respon-
dents in the webinar versus in-person condition reporting
‘more effort’ (100% vs 67%) (Figure 2).
Satisfaction
Participants rated AFIX consultations highly in terms of
helpfulness (mean = 4.7, SD = 0.5), ease of understanding
(mean = 4.7, SD = 0.7), convenience (mean = 4.6, SD = 0.7),
and length of consultation (mean = 4.5, SD = 0.7). Partici-
pants also gave high marks to the importance of individual
program components, including the clinic’s immunization
coverage assessment report (mean = 4.6, SD = 0.7), the
missing immunization report (mean = 4.7, SD = 0.7), the
duplicate client report (mean = 4.3, SD = 0.9), the state
and national comparison (mean = 4.2, SD = 0.8), the county
and regional comparison (mean = 4.5, SD = 0.8), and the re-
minder/recall training (mean = 4.5, SD = 0.8). Participants
in the two intervention conditions expressed the same high
levels of satisfaction on these measures (Table 2). In terms
of intervention delivery mode, 30 of 31 participants who
received webinar consultations indicated a preference for
that mode. All 30 participants who received in-person con-
sultations indicated a preference for in-person delivery.
Cost
The intervention cost per clinic was $152.45 for the in-
person condition and $99.95 for the webinar condition
(Table 3).
Discussion
This process evaluation compared two modes of delivering
an immunization quality improvement program to primary
care clinics in North Carolina. We found that AFIX consul-
tations delivered by interactive webinar versus in-person
office visit elicited similar levels of participation, and
healthcare providers in both groups showed sustained
improvement with regard to an important intermediate
outcome, confidence in using reminder/recall systems.
We were also encouraged to find that participant satisfac-
tion was very high overall and comparable between delivery
modes. When it came to program cost, however, webinar









Entry of historical doses
Targeting of patients 1 visit short of completion







Figure 2 Clinics reporting more effort in programmatic activities at five-month follow up after in-person (k = 30) and webinar
(k = 31) consultations.
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one-third less per clinic. Taken together, these findings
suggest that webinar delivery deserves serious consider-
ation by state health departments seeking to implement
adolescent AFIX.
Several factors may explain the somewhat surprising
success of webinar delivery. First, the novelty of the
videoconferencing software we employed may have elic-
ited interest from our participants, who, as healthcare
providers, likely had a higher degree of technological
sophistication than the general public. At the very least,Table 2 Mean satisfaction ratings
In-person Webinar
Mean (SD) Mean (SD)
Overall program satisfactiona
Helpfulness 4.7 (0.6) 4.7 (0.4)
Ease of understanding 4.7 (0.8) 4.7 (0.4)
Convenience 4.5 (0.8) 4.5 (0.8)
Length of consultation 4.7 (0.5) 4.4 (0.8)
Rating of program componentsb
Assessment report 4.6 (0.6) 4.6 (0.9)
Missing immunization report 4.8 (0.5) 4.6 (0.9)
Duplicate client report 4.4 (0.9) 4.3 (1.0)
State/national comparisonc 4.2 (0.8) 4.3 (0.9)
County/regional comparison 4.5 (0.8) 4.5 (0.9)
Reminder/recall training 4.4 (0.7) 4.5 (0.9)
Note. In-person and webinar conditions had comparable satisfaction scores
(all comparisons p > 0.05).
aItems assessed with a five-point response scale ranging from ‘strongly disagree’
(1) to ‘strongly agree’ (5).
bItems assessed with a five-point response scale ranging from ‘very
unimportant’ (1) to ‘very important’ (5).
cExcludes data missing for clinics in the in-person (n = 1) and webinar
(n = 1) conditions.we can conclude that any technical difficulties participants
faced were not burdensome enough to preclude participa-
tion or greatly detract from overall satisfaction. Second,
we estimated that, despite covering the same content,
webinar consultations lasted about thirty minutes longer
on average than in-person consultations; increased inter-
action time may have supported webinar delivery. Finally,
we can report anecdotally that providers often resched-
uled webinar consultations, but rarely did so for those
delivered in-person. Having greater flexibility may have
allowed webinar participants to schedule consultations
when they could most fully attend to programmatic activ-
ities. Whatever the case, this study adds to a small, but
growing body of literature that suggests that internet-
based approaches such as videoconferencing are at least
as effective as—and perhaps even more effective than—
in-person instruction for delivering continuing education
to health professionals [14-16].Table 3 Average cost per clinic for AFIX consultations
In-person Webinar
Staffing ($20.51/hour)
Consultation preparation (2 hours) $41.02 $41.02
Consultation (1 hour in-person,
1.5 hours webinar)
$20.51 $30.77
Travel to consultation (2 hours) $41.02 n/a
Travel
Mileage (125 miles/consultation @
$0.30/mile)
$37.50 n/a
Lodging and meals $12.40 n/a
Mailings n/a $15.58
Webinar license ($390/year) n/a $12.58
Total $152.45 $99.95
Note. The 30 in-person AFIX consultations required three overnight trips that
incurred lodging and meal expenses of $372.
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offers three main advantages. First, the lower cost of webi-
nar consultations could dramatically extend the reach of
AFIX. In our own study, for example, we could have
reached an additional 15 clinics, serving about 17,700
adolescents, had we used the funds spent on in-person
consultations for webinar consultations instead. Second,
in addition to cost, webinar delivery eliminates the incon-
venience and disruption state health department personnel
experience when traveling to clinics for in-person consulta-
tions. Travel can pose an especially difficult obstacle in
states, such as North Carolina, that periodically prohibit
state employees from traveling as a way to manage their
surprisingly frequent fiscal crises. Third, webinar delivery
may also expand who can deliver AFIX by making geo-
graphic proximity unnecessary for program implemen-
tation. For instance, program officers at CDC could
deliver webinar consultations nationwide, thereby central-
izing program planning and dissemination and reducing
the burden on state health departments [17]. Clinics in
rural areas may be especially well-served by webinar visits.
The potential advantages of webinar delivery are, thus,
substantial in terms of flexibility and efficiency, although
these benefits must be balanced against disadvantages
such as reduced ability to collect observational data about
clinic setting and work flow.
One aspect of our program that warrants special
comment is the goal to raise providers’ use of patient
reminder/recall systems. Reminder/recall is prioritized
in the AFIX program because the strategy is associated
with increased immunization rates for both young children
and adolescents [18,19]. Providers in our study also priori-
tized reminder/recall use as a focus of their own quality
improvement efforts, and we found that our intervention
successfully increased participants’ confidence in using
such systems regardless of delivery mode. However, des-
pite goal setting and improved confidence, subsequent
use of reminder/recall systems was modest, with only
about one-third of participants reporting the activity at
five-month follow-up. Lack of staff time was the primary
barrier to use. This finding corresponds with existing
research, which suggests that conducting reminder/recalls
is difficult in the context of primary care because of
the burden associated with updating patients’ contact
information and then generating calls or mailings [17].
Given the recent success of centralized versus provider-
based programs for reminder/recall [17,19], state health
departments should carefully consider how much to
emphasize reminder/recall training during AFIX con-
sultations since conducting reminder/recalls directly at
the state level may ultimately be more effective.
In terms of strengths, this study employed a strong
research design, including random allocation of clinics
to study conditions, to compare intervention deliverymodes among high-volume primary care clinics. Limita-
tions include a modestly-sized, state-specific sample and
the use of self-reported measures to assess program partici-
pation. Our calculation of program cost per clinic focused
narrowly on intervention delivery so as to compare delivery
modes; we excluded factors, such as overhead expenses,
costs incurred by providers, and quality adjusted life years,
that would be needed to determine overall program costs
or to conduct a comprehensive cost-effectiveness analysis.
One author (AD) delivered all in-person and webinar con-
sultations; this consistency maximized the comparability
of the study groups, but other immunization specialists
may achieve higher or lower levels of participation and
satisfaction. Additional research is needed to understand
how our findings generalize to clinics with lower patient
volumes, particularly given that small clinics may have re-
duced access to the technology needed to support webinar
delivery.
Conclusions
Quality improvement programs are urgently needed to
address the underuse of adolescent vaccines, and the
CDC’s AFIX model offers a strong foundation for these
efforts. This study provides evidence to suggest that
webinar delivery could substantially increase the reach of
AFIX without adversely affecting participant experience.
As adolescent AFIX undergoes further development,
program planners should continue to pilot consultation
materials via webinar. Given that adolescent AFIX will
be disseminated nationally, maximizing the program’s
efficiency is of vital importance for supporting state health
departments as they seek to make the best use of
increasingly constrained resources.
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